ArticleInternational medical case reports journal2025
From Eruptive Xanthoma to Acute Pancreatitis: Clinical Warning and Implications of Rapid Disease Progression.
Article in International medical case reports journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Xanthoma is a common cutaneous manifestation typically associated with abnormal lipid metabolism, particularly hyperlipidemia. Both hyperlipidemia and hyperglycemia are significant components of metabolic syndrome and can elevate the risk of pancreatitis. Acute pancreatitis is a serious inflammatory disease that can be life-threatening and may be triggered by various factors, including hyperlipidemia. In conclusion, there appears to be a potential link between xanthoma, hyperlipidemia, and acute pancreatitis, which seem to be distinct diseases. By analyzing the diagnostic and treatment processes for this patient, we found that early identification and intervention in xanthoma patients are crucial. This approach not only aids in controlling the progression of xanthoma but also helps prevent a range of serious complications associated with hyperlipidemia, such as acute pancreatitis. Ultimately, this reduces the impact of the disease on health and enhances the quality of life and survival rates for patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.